KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

ACRX Predictions History

3 years ago
Naz Islam predicted that ACRX for 2021-01-19 is going

Rank:

3 years ago
JS predicted that ACRX for 2020-11-06 is going $1.89 (30.34%)

3 years ago
JS predicted that ACRX for 2020-11-04 is going $1.80 (-1.64%)

3 years ago
JS predicted that ACRX for 2020-11-03 is going $1.78 (-2.20%)

3 years ago
JS predicted that ACRX for 2020-10-21 is going $1.69 (0.00%)

3 years ago
JTF Incorporated predicted that ACRX for 2020-10-21 is going

Rank:

4 years ago
JS predicted that ACRX for 2019-12-30 is going $2.20 (3.77%)

4 years ago
joe1234 predicted that ACRX for 2019-07-02 is going $2.59 (7.02%)

4 years ago
joe1234 predicted that ACRX for 2019-06-20 is going $2.48 (5.08%)

4 years ago
joe1234 predicted that ACRX for 2019-06-19 is going $2.48 (2.48%)

Click to get the best stock tips daily for free!

About AcelRx Pharmaceuticals

AcelRx Pharmaceuticals AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai... ACRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT